Denizen Pharmaceuticals India Private Limited, a active private limited company, was established on 13 December 1993 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1993PTC056429. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.48 M.
It upholds a compliant status. Its leadership includes Nikunj Gupta (Director), Anuj Gupta (Director), Praveen Kumar Gupta (Director). Past directors included Navin Kumar Gupta, Dhiraj Kumar Gupta. It holds ₹7.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Wz-8, First Floor, Manohar Park Opposite Metro Pillar No. 41, Rohtak Roa, D, New Delhi, Delhi, 110026.
U74899DL1993PTC056429
056429
13 December 1993
₹2.50 M
₹2.48 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Denizen Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikunj Gupta | Director | 04 Jul 2012 | Current |
| Anuj Gupta | Director | 04 Jul 2012 | Current |
| Praveen Kumar Gupta | Director | 13 Dec 1993 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Jul 2012 | Past |
| Pramod Abcsdd | Director | 04 Jul 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Denizen Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.77% decrease. The company also saw a substantial fall in profitability, with a 77.19% decrease in profit. The company's net worth moved up by a moderate rise of 1.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Denizen Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2025 | Others | ₹7.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Denizen Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Denizen Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Denizen Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 7.00 M with Charge ID 101110536 was registered on 06 Jun 2025. was documented.
Progress on Denizen Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Denizen Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Nikunj Gupta was appointed as a Director was appointed as a Director on 04 Jul 2012 & has been associated with this company since 13 years 4 months . was documented.
Anuj Gupta was appointed as a Director was appointed as a Director on 04 Jul 2012 & has been associated with this company since 13 years 4 months . was recorded as a recent event.
Progress on Praveen Kumar Gupta was appointed as a Director was appointed as a Director on 13 Dec 1993 & has been associated with this company since 31 years 11 months . was documented.
The CIN of Denizen Pharmaceuticals India Private Limited is U74899DL1993PTC056429.
Denizen Pharmaceuticals India Private Limited is headquartered at Wz-8, First Floor, Manohar Park Opposite Metro Pillar No. 41, Rohtak Roa, D, New Delhi, Delhi, 110026.
Denizen Pharmaceuticals India Private Limited was incorporated on 13 December 1993.
The current directors of Denizen Pharmaceuticals India Private Limited are
The primary industry of Denizen Pharmaceuticals India Private Limited is Manufacturing.
Denizen Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Denizen Pharmaceuticals India Private Limited is ₹2.50 M, and the paid-up capital is ₹2.48 M.
The compliance status of Denizen Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX